Skip to main content

Aprea Therapeutics, Inc.

APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781983

No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Aprea Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
+3 vs. Q3 2021
Shares held
3.61M
−1.35M (−27.2%) vs. Q3 2021
Total value
$10.4M
−$15.0M (−59.1%) vs. Q3 2021
New holders
12
9 more added
Sold out
9
11 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 41 institutions
Q1 2021: 67 institutionsQ2 2021: 50 institutionsQ3 2021: 39 institutionsQ4 2021: 41 institutionsQ1 2022: 40 institutionsQ2 2022: 34 institutionsQ3 2022: 27 institutionsQ4 2022: 25 institutionsQ1 2023: 18 institutionsQ2 2023: 19 institutionsQ3 2023: 21 institutionsQ4 2023: 20 institutionsQ1 2024: 24 institutionsQ2 2024: 28 institutionsQ3 2024: 22 institutionsQ4 2024: 26 institutionsQ1 2025: 26 institutionsQ2 2025: 23 institutionsQ3 2025: 23 institutionsQ4 2025: 22 institutionsQ1 2026: 22 institutionsQ2 2026: 27 institutions
Value heldQ4 2021: $10.4M
Q1 2021: $45.4MQ2 2021: $31.9MQ3 2021: $25.6MQ4 2021: $10.4MQ1 2022: $4.50MQ2 2022: $1.52MQ3 2022: $1.11MQ4 2022: $521.3KQ1 2023: $3.77MQ2 2023: $2.78MQ3 2023: $3.66MQ4 2023: $4.36MQ1 2024: $10.8MQ2 2024: $8.48MQ3 2024: $5.50MQ4 2024: $6.83MQ1 2025: $3.78MQ2 2025: $3.07MQ3 2025: $2.39MQ4 2025: $1.45MQ1 2026: $1.71MQ2 2026: $1.90M
Institutions holding APRE and their total value by quarter
QuarterHoldersValue
Q2 202627$1.90M
Q1 202622$1.71M
Q4 202522$1.45M
Q3 202523$2.39M
Q2 202523$3.07M
Q1 202526$3.78M
Q4 202426$6.83M
Q3 202422$5.50M
Q2 202428$8.48M
Q1 202424$10.8M
Q4 202320$4.36M
Q3 202321$3.66M
Q2 202319$2.78M
Q1 202318$3.77M
Q4 202225$521.3K
Q3 202227$1.11M
Q2 202234$1.52M
Q1 202240$4.50M
Q4 202141$10.4M
Q3 202139$25.6M
Q2 202150$31.9M
Q1 202167$45.4M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding APRE in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc696,826$2.00M0.00%−20,589−2.9%Reduced
Pura Vida Investments, LLC433,859$1.25M0.13%+433,859New
Kennedy Capital Management, Inc.336,730$966.0K0.02%−5,756−1.7%Reduced
Morgan Stanley326,210$936.0K0.00%+141,246+76.4%Added
Renaissance Technologies LLC281,923$809.0K0.00%+281,923New
BlackRock Inc.232,211$667.0K0.00%−122,064−34.5%Reduced
JPMorgan Chase & Co194,814$559.0K0.00%+8,831+4.7%Added
Citadel Advisors LLC163,261$469.0K0.00%+41,312+33.9%Added
Geode Capital Management, LLC150,143$430.0K0.00%−48,196−24.3%Reduced
PDT Partners, LLC142,600$409.0K0.03%+54,866+62.5%Added
Bridgeway Capital Management, LLC75,000$215.0K0.00%00.0%Unchanged
Group One Trading, L.P.69,840$200.0K0.00%−3,001−4.1%Reduced
Susquehanna International Group, LLP65,789$189.0K0.00%−133,864−67.0%Reduced
Susquehanna Fundamental Investments, LLC49,100$141.0K0.00%00.0%Unchanged
Virtu Financial LLC41,955$120.0K0.01%+41,955New
State Street Corp40,832$117.0K0.00%00.0%Unchanged
Northern Trust Corp34,952$100.0K0.00%−456−1.3%Reduced
Magnus Financial Group LLC33,981$98.0K0.02%+33,981New
XTX Topco Ltd27,285$78.0K0.04%+27,285New
Goldman Sachs Group Inc23,824$68.0K0.00%−120,934−83.5%Reduced
Tower Research Capital LLC (TRC)22,026$64.0K0.00%+18,433+513.0%Added
Jane Street Group, LLC21,202$61.0K0.00%+7,043+49.7%Added
Verition Fund Management LLC20,128$58.0K0.00%+27+0.1%Added
ExodusPoint Capital Management, LP17,326$50.0K0.00%+17,326New
Bank of New York Mellon Corp16,843$48.0K0.00%00.0%Unchanged
Blackstone Group Inc.16,590$48.0K0.00%00.0%Unchanged
Dynamic Technology Lab Private Ltd15,173$44.0K0.00%+15,173New
Squarepoint Ops LLC14,880$43.0K0.00%+14,880New
Quantamental Technologies LLC13,752$39.0K0.02%00.0%Unchanged
Engineers Gate Manager LP13,395$38.0K0.00%+13,395New
Royal Bank of Canada11,700$34.0K0.00%−8,900−43.2%Reduced
Federated Hermes, Inc.3,505$10.0K0.00%+1,352+62.8%Added
Sugarloaf Wealth Management, LLC1,500$4.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,050$3.00K0.00%+250+31.3%Added
Kistler-Tiffany Companies, LLC500$1.00K0.00%00.0%Unchanged
Macquarie Group Ltd183$1.00K0.00%00.0%Unchanged
FMR LLC200$1.00K0.00%+200New
NEXT Financial Group, Inc103$00.00%−11,244−99.1%Reduced
Bank of America Corp140$00.00%−10,166−98.6%Reduced
Wells Fargo & Company95$00.00%+95New
UBS Group AG75$00.00%+75New
Versant Venture Management, LLC0$00.00%−1,259,662−100.0%Sold out
Redmile Group, LLC0$00.00%−694,918−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−53,201−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,970−100.0%Sold out
Skandinaviska Enskilda Banken AB (publ)0$00.00%−2,160−100.0%Sold out
Citigroup Inc0$00.00%−1,108−100.0%Sold out
Penserra Capital Management LLC0$00.00%−490−100.0%Sold out
Koshinski Asset Management, Inc.0$00.00%−55−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−40−100.0%Sold out
Coastal Investment Management, L.P.––––Not filed